# Summit Therapeutics Inc.: Form 8-K, filed Sep 29, 2026

- Company: [Summit Therapeutics Inc.](/companies/smmt.md) (CIK 1599298)
- Form: 8-K
- Filed: 2026-09-29
- Accepted by EDGAR: Sep 28, 2026, 21:39 ET
- Period: 2026-09-28
- Accession: 0001193125-26-405776
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1599298/000119312526405776/d178892d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1599298/000119312526405776/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1599298/000119312526405776/d178892d8k.htm

Filed Sep 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-405776. Last ingested by Listed: Nov 4, 2026, 19:36 ET. No prices; not investment advice.
